Update on myocarditis – review (RCD code: III-6A.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 6
Abstract
Myocardits is an inflammatory disease of the myocardium diagnosed by established histological and immunohistochemical criteria. The true incidence of myocarditis is unknown. There are numerous potential etiologic factors, however, in developed countries the most frequent cause of myocarditis are viral infections. The pathogenesis of viral myocarditis and subsequent dilated cardiomyopathy (DCM) is not fully understood and differ between viruses. The progression of acute cardiac inflammation to DCM is the three-phase process, including viral (cytopathic), (auto)-immunulogic, and recovery or myopathic phase. Cardiac symptoms are variable and include reduced functional capacity due to dyspnoe and/or fatigue, palpitations, precordial chest pain which result from associated pericarditis or coronary artery spasms.Diagnostic work-up in myocarditis is multistage and requires integration of clinical symptoms, laboratory and imaging data, all of which have an adjunctive role to the endomyocardial biopsy (EMB), which is final and ultimately decisive diagnostic tool. All patients with clinically suspected myocarditis should undergo detailed echocardiographic examination to rule out other cardiac diseases and to assess and monitor changes in chamber size, wall thickness, ventricular systolic and diastolic function, or pericardial effusions. Nevertheless, cardiac magnetic resonance is superior to echocardiography in terms of non-invasive tissue characterization. Recent trails have provided substantial body of evidence for additional myocarditis-specific or tailored therapies, including anti-viral and immuno-modulating therapy such as high dose intravenous immunoglobulin, immunoadsorption, and immunosuppression. JRCD 2014; 1 (6): 4–9
Authors and Affiliations
Pawel Rubis, Piotr Podolec
Keywords
Related Articles
- EP ID EP245434
- DOI 10.20418/jrcd.vol1no6.118
- Views 85
- Downloads 0
Arrhythmogenic right ventricular cardiomyopathy complicated by thrombus formation (RCD code: III-4)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is caused by replacement of myocardial cells by lipocytes and fibrocytes. The disease is associated with life-threatening ventricular arrhythmias. Echocardiography...
A 79‑year‑old man with pericardial tumor (RCD code: VI‑1B.4)
A huge pericardial tumor was incidentally detected in 79 year old man during routine transthoracic echocardiography which was not presence in previously performed echocardiography studies (the last was 4 mounths ago). T...
Genetics and genetic testing in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare disease with a high mortality and complex pathomechanism. Recent studies suggest an important role of genetic factors in the development of PAH. It was shown that patients...
Spontaneous implantation of a left atrial myxoma into the left ventricle (RCD code: VI‑1A.1)
Myxomas are one of the most common cardiac tumors. In 70–80% of cases they are located in the left atrium, 10–20% in the right atrium and in less than 10% in ventricles. We report a case of a 60-year-old patient after my...
Right ventricular free wall motion abnormalities as a simple method of assessment in patients with pulmonary hypertension (RCD code: II‐1A.O)
Background: Pulmonary hypertension (PH) is a cardiovascular pathology leading to right-sided heart failure. A qualitative assessment of right ventricular (RV) function in echocardiography provides valuable information on...